Phase 1/2CompletedGeroscience intervention

Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults

Sponsor
University of Colorado, Boulder (Academic or other)
Enrollment
30 enrolled
Conditions
Aging
Interventions
Niagen™; Placebo
Ages
adults, older adults
Registry
NCT02921659

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to assess the efficacy of supplementation with the Nicotinamide Adenine Dinucleotide (NAD+) precursor compound, Nicotinamide Riboside (NR), for improving physiological function (vascular, motor, and cognitive) in healthy middle-aged and older adults.

Primary outcomes

  • Incidence of treatment emergent adverse events

History

  1. Last registry update

  2. Primary completion

  3. Registered

  4. Started

Papers citing this trial